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IncreaaedQT IntervalDispersionFollowing
Peat-DialvticDecreaaeof Potassiumand
Magnesi~m:A Modelto Studythe Repolarizatlon
ChangesAssociatedto ElectrolyteAbnormalities
E.H. Loeati, G. Bagliani, M. Stramba-Badiale, P.Saronio, M. Timio. Cerdro
Fisiologia Clinica a Ipartensione, Univof Milan and Nephrology Unit,
Foligno Hospital, Italy
In patients with chronic renal diaease requiring recui’rent hemodialysis (HD),
a marked decrease of serum K+ and Mg+2between the pre- and post-dialytic
phases is obaetved, often associated with onset of cardiac arrhythmias. The
effect of K+ and Mg+2gradients on ECG profile was studied in 20 consecutive
HD patients (17 males, mean age51 +17 years), with the following exclusion
criteria: 1) Coronary artery disease; 2) NYHA class >2 or ejection fraction
.40%, 3) Ventricular hypertrophy; 4) LBBB or RBBB; 5) Atrial fibrillation.
Serum ‘mncentrations (mEq/L) of K+, Mg+2, Na+, Ca+2, and Cl- were
monitored, and absolute QT duration (msec), mrrected QT interval (QTc,
msec), and two repolafizstion dispersion indexes: QTc fmax-min(msec) and
dispersion coefficient (DC = OTCstandard deviatiordmean C?TCx 100) were
measured from 12-lead ECGSin pre- and post-dialytic phaaes.
K+ f@+2 Q~ QTc QTcmax-min DC
Pre-diaiysis 5.2+ 0.8 2.8+ 0.6 352+32 399+26 53+21 4.6+ 1,5
Post-dialysis 3.5& 0.6 2.1+ 0.4 374k 59 428k 38 69k 65 7.2+ 4.9
pvalues <0.0001 < 0.000t 0.05 0.0005 0.01 0.01
Thua, the peridialytic K+ and Mg+2 gradienta induce a significant in-
creaae in QT duration and dispersion of ventricular repolarization, with major
changea in T and U wave morphology. The association between serum
electrolytes changes and abnormalities of ventricular depolarization might
contribute to the understanding of the ionic basia involved in QT interval
prolongation.
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El7381 EarlyandPredischargeAepirinAdministrationAmongPatientsWithSuspsctedAcuteMyocardial
Infarction:CurrentClinicalPracticeinthe United
States
M. Burns, R.C. Becker, J.M. Gore, C. Lambrew, W. French, W. Rogers, for
the National Regisby of Myooardial Infarction (NRMI-2) Investigators.
Univeraily of Massachusatfs Medical School, Worcestefi MA, USA
Aspirin (ASA), a widely available, inexpensive, and well-tolerated platelet
inhibitor, is recommended for patients with acute coronary syndromes, in-
cluding myocarrfial infarction (Ml). We determined early (<24 hours) and
prediacharge ASA adminiatrstion among 220,171 patients with suspect%
Ml. Recipients (n= 165,122) (74.9%) were younger, more often male, arrived
at the hoapitsl earfier,and were more Iikelytobe Killip Class Iorll (p < 0.001).
Patients treated with thrombolytiee (n = 67,564), PTCA (n = 14,395) and no
reperfusion (n = 137,468) received ASA 90%, 62%, and 67% of the time,
respectively. By logistic regression analysis independent predictors of early
ASA use included ST segment elevation (OR 1.41; 1.17-1.69; p = 0.0001)
and male sex (OR 1.28; 1.11-1.46; p =0.0001). Prior Ml (OR 0.74; 0.62-0.66;
p = 0.0001), previous bypasa grafting (OR 0.76; 0.61-0.95; p = 0.02) and
not low-risk categorization were inveraely associated with early ASA use.
In-hospital recurrent Ml (OR 0.94; 0.62-0.99; p = 0.04), atroke (OR 0.73;
0.67-0.68; p = 0.0001) and death (OR 0.24; 0.22-0.26; p = 0.0001) were
significantly reduced among earty ASA users. Nearly one-third of patients
surviving their Ml did not receive ASAat hospital discharge. We conclude that
ASA ia currently underutilized in routine clinical practice as a primary or ad-
junotive form of therapy in Ml, especially among patients at risk for recurrent
thrombotic events. ASAforseoondary prevention may also be underutilized.
National ef70rtsto increaae ASA use should improve the standard of care.
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CooperativeCardiovascularProject(CCP)-
Underuseof QualityIndicatorsforAcuteMyocardlal
InfarctioninMedicarePatientsin NewYorkState
M. Malach, R.P.Nenner, /PRO, Lake Success, NY USA
A national Cooperative Cardiovascular Project (CCP) under the direction
of The Health Care Financing Administration (HCFA) assessed the care of
hospitalized patienta with acute myccardial infarctions (AMI) during an eight
month period of 1994. Nationally there were 220,000 with 17,000 in New York
(NY). As a result of chart abstractions, the data clearly auggeat that there are
significant opportunities for improvement in hospital based care.
AMI is a leading cause of death, The project was to demonstrate compli-
ance with ten quality indicator for AMI, arrived at by an American College
of Cardiology (ACC) Task Force with HCFA. Increased compliance would
improve the outcome of AMI care especially in medicare patienta. Three
cruciai quality indicators – aspirin, beta blockers and timely thrombolytics
were used noticeably Ieaa in the older and the sicker patients. New York
mortality for AMI of 16.2% (nationally 18.6Yo)can be explained by a median
age of 75 and 48% anterior AMIs. The benefits of ACE inhibitors for low left
ventricular ejection fraction and the non-use of calcium channel blockers was
documented. Data for the 10 indicators will be presented.
IPRO has provided each of 205 hospitals with their data and peer and
national comparisons and conducted regional meetings and teleconferences
to review the repotis and methods of increasing compliance with the ten
quality indicators..Successful examples of quality improvement programs
with protocols and care mapa will be presented. Outcome improvement for
AMI in medicare’patientsare expected on new reviews in succeeding months.
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1738-31Theparadigmf~rAnti-plateletEffectonContinuous
12-LeadST-SegmentRecoveryinAcuteMl
M.W. Krucoff, R.A. Barrington, D.J. Moliterno, C.L. Green, K.M. Trollinger,
A. Kristinsson, C.D. Morgan, J. Burks, T. Nygaard, J.E. Pope, E.J. Topol,
R.M. Califf. Duke University Medica/ CenteL Durham, NC, USA
Parameters of continuous 12-lead ST-segment recovety correlate with an-
giographic patency, therapeutic drug effect and clinical outcomes. In the
PARADIGM study the effects of the anti-platelet agent Iamifiban (150-400
kg bolus, 1-2 @rein infusion) randomized vs. placebo in pts with <6 hra
cheat pain & ST elevation given tPA and ASA were assesaed with con-
tinuous 12-lead ST-segment recovery analysis in 244 pts with analyzable
data. ST parameters included presenca of >50% ST recovery at 90 min
(ST-PATENCY);time to ST recovety stable for >4 hrs (STABLE); total ST
deviation curve area (AREA); and re-elevation >150wVafter STABLE (LATE
ST). Results were, as% or median (25th, 75th % ile):
Parameter Placebo Lamifiban P-value
# PTS 7e 165
eOMinST.Patency 63°A 60”/6 0.007
STABLE(rein) 130(45,253) 89 (31,149) 0.0039
AREA(uV-min) 6256(1370,13390) 4736(O,10123) 0.028
LATEST 240/n 12% 0.026
Thua, even with a fairly small sample size, the desirable effects of platelet
inhibition with Iamifiban are evident compared to placebo, with a 30-50%
reduction in continuous ST parameters of reperfusion speed, atability, total
infarct “burden” and recurrent ischemia.
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R lntrav~n~us.rgstrobenversus~eParinas
co-medicationto altepleeeinthetreatmentof acute
myocardialinfarction;preliminaryresultsof the
ARGAMIpilotstudy
F.Vermeer, A. Vahanian, P.W.FeIs, P.Besse, D. Radzik, M.L. Simoons,
Acadamic Hospital Maastricht, University of Limburg, Tha Netherlands
Intravenous argatroban (a new synthetic thrombin inhibitor derived from
arginine) was compared to heparin as co-medication to altepiaae in the
treatment of patients with acute myocardial infarction in a 2:1 double blind,
randomized trial using a double dummy technique. Argatroban was given aa
a bolua of 100 @kg prior to the starl of thrombolytic therapy, followed by an
infusion of 3 @kg/rein. Heparin was given as a bolus of 5000 IU, followed
by an infuaion of 1000 IiJ/hour, titrated against (a)PTT. Alteplase was given
according to the accelerated regimen as used in GUSTO. Acute coronary
angiography was scheduled for all pts at 90 min after atart of the infusion and
after 5 to 10 days.
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Results:
Argatroban Heparin
Number of patients 82 45
TIMI 0/1 flowat 90 min 23 26% 8 18%
TIMI 2 flowat 90 min 15 18”A 7 16”A
TIMI 3 flowat 90 min 46 56% 30 67”h
TIMI 2/3 flowat day 5-10 4S/56 86% 29/33 86%
The differences in patency rate were not statistically significant. The
argatroban infusion was tolerated well in all patients.
Conclusions: Inthispilotstudy intravenous argatroban (aswellasheperin)
given togethar with alteplaee in the treatment of acute myocardial infarction
leads to restoration of TIMI 3 flow in a sizable propotiion of patients. A large
randomized trial is needed to decide the optimal dosage of argatroben and
to assess the efficacy of argatroban compared to heperin.
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1738-51MyoglObin.and~~~p~nin~f~~~~~,nv~~iv~
Assessingof CoronaryReperfusionAftsr
ThrombolyticTherspy
C. Heeschen, C.W. Harem, B.U. Goldmann, T. Meinetiz. UrWersitiyHospita/
Eppendort Dept. of Cardiolog~ Hamburg, Germany
Early reperfusion is an important predictor of short- and long-term progno-
sia in developing acute myocardial infarction (AMI). Reliable noninvasive
assessment of suceesa or failure of thrombolyfic therapy may allow rescue
angioplasty or additional application of thrombolytics to achieve reperfusion.
In a prospective study with 84 patients (pts.) undergoing thrombolysis serum
samples were taken just before and 2 hours after stari of thrombolysis to
determine the predictive value of myoglobin (Myo), troponin T (TnT), and tro-
porrin I (Tnl) for assessing corona~ reperfusion. The perfusion status of the
infarct-related artety was assessed angiogrephically and TIMI 3 was defined
es successful repduaion. The initial slope (2 h value – baseline value/2 h)
and the relative increase (index = 2 h value/baseline value) of the markers
in successful (n = 45) and unsuccessful (n = 19) thrombolytic tharapy were
compared by the area under the ROC curve (AUC).
Results:
AUC values Myo TnT Trd
Oneetofcheetpsin index alope index slopa index alope
Pfe. <3 h 0.74 0.6S 0,59 0.65 0.72 0.69
Pfa. >3 h 0.69 0.82 0.72 0.76 0,ss 0.87
Resultingthreshold index 10 elopeO.5n@mlx h Index50
Conclusion: The index of Myo had the highest predictive value and AUC
due to earlier rise. The diagnostic value of Tnl index was comparable to that
of Myo and superior to TnT (slope, p < 0.01). Therefore Tnl may be the
preferred marker due to its cardio-specificity. However, for patients treated
<3 h after onset of chest pain, the predictive value for all 3 markers was
limited.
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n7386 DoesSTATReportingofSerialSerumhkerkers(CK-MBsndMyoglobin)Aidin EarlyDetectionand
TreatmentD$cisionsfor AcuteMl?
W.B. Gilber, for the Smartt Investigators, MIT! Cwrdinating Center.
Univeraityof Washington, Seaff/e, WA, USA
The diagnosis of Acute Ml is often made hours after hospital admission,
when treatment options to salvage myocerdium are limited. To determine if
aerial results of CK-MB and Myoglobin (MYO) increase the early diagnosis
and appropriate treatment rates of patients having Mls or change traditional
triage dacisions in the Emergency Depafiment (ED), we randomized 6,500
patients (age =-25 years) at 12 EDs in Canada and the US to either STAT
reporting of CK-MB and MYO or to routine hospital atendard reporIing of CK
values (ueually >3 hours). Patients with chest pain were enrolled into the
trial. Serum samples were obtained at baseline and 1 hour. In the first interim
analysee of 2,500, patients the mean age of those randomized to STAT
reaults was 59.5 yeare and 59.8 years for patients randomized to routine
results. Malea comprised 5i’.5Yoof patients in the STATgroup and 58.9% in
the routine group. In the STATgroup, 13.1% of patients had evidence of Ml
vereua 12.OYOin the routine group (using usual enzyme and ECG criteria).
The trial will be completed in September of 1998. Repotting of final results
will include: initial treatment rates for AMI, serial marker sensitivities and
specificities, admission and discharga ratea, and in-hospital complications
will be reported.
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[739-1]TheEuro-ARTStudY,AnAna,ysisofthelnitial
EuropeanExperiencewiththeAngioJetRapid
ThrombectomyCatheter
J. Hamburger, M. Brekke, C. di Mario, W. Wijns, M. Amor, J. Marco,
M. Bertrand, R. Erbel, P.Serruys, Thorsxcerrter,Dijkzigt Hospita/
Roffenlam, The Netherlands
The occurrence of fresh thrombus during percutaneous coronary interven-
tions, especially in patients (pts) with diffusely diseased saphenous vein
bypass grafts (SVBG) is associated with an increased incidence of pmeadu-
ral complications and clinical incidents. The AngioJet Rapid Thrombacfomy
Catheter (ART) (Poasis Medical, Minneapolis, Mn) was deaigned to remove
thrombus via a high-velocity Ventouri effect induced vacuum. Here we report
on the initial evaluation of the safety and efficacy of successful pre-treatment
with ART in pts with angiographic prove of thrombus both intramronary or in
SVBG’S.Thirty-five pts (28 male, age 60 + 12 yrs) wera treated (6 LAD, 5
LCX, 15 RCA, 9 SVBG). Seven pts had prior PTCA, 13 prior CABG. Ten pts
presented with acute myocardial infarction (AMI). The angina classification
was Ml in 8, class IWIV in 27 pts. The AHA/ACC lesion classification was
BI n = 1, B2 n = 11 and C n = 14. Lesion length was 31 + 28 mm, target
lesion calcification present in 14 pts. Co-morbidity was diabetes n =2, hy-
pertension n = 11,hypercholesterolemia n = 14 or a positive family history in
10. Angiographic prove of thrombus removal was complete in 19, partial in 9
and absent in 7 pts. Stent.implantation was performed in 24 pts (69%), and
iv. Rheopro administered in 9 (26%). Procedural complications were ART
induced asystole requiring RV pacing in 9, acute chest pain in 10 and dis-
section in 8 pts. Q wave Ml occurred’in 3 pts of those who initially presented
with AMI. Thera were no deaths, re-PTCA or CABG during the index hoapital
stay. Thus, ART success was obtained in 28 (60%), procedural success in
30 pts (88%). Conclusion: These preliminary data suggest that ART is safe
and affective in removing thrombus during PTCA.
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1739-21AnalyaisandCOmpari$OnOfPlatel$tAggregation
withHigh-SpeedRotationalAtherectomy
M. Reisman, B. Shuman, R. Fei, D. Dillard, S. Nguyen, L. Gordon. Swedish
Medical Center and Boston Scientific Corporation Northwest, Redmond,
WA, USA
Shear induced platelet aggregation has previously been demonstrated. How-
ever, to date no date exists as to the effects of rotational atherectomy on
platelet aggregation. An in vitro model aimed at analyzing shear stress in
blood using the Rotablato@ system was developed. The design consisted of
a silicone tubing with a 2.5 mm inner diameter through which a 2.0 mm burr
was passed. A total of 16 samples of freshly drawn heparinized mini-swine
blood were pumped (10 ml/min) through the model, subjected to ablation
Spaedaof 180,000, 140,000 and Orpm (control), collected and immediately
analyzed. The quantity and size of platelet aggregates was established uaing
an optical microscopytechnique, (Fei et al: Exp. Hemat. 1998; 2:, 1070). The
following data was collected:
AggregationTests* RotationalSpeed
1S0 krpm 140 krpm Control
PlateletAggregates >20 #m 7137 * 1993 2255 & 605 S33• 258
(perml blood)
*n = S foraach group,p <0.0001 for all groupa
Platelet aggregates were generated at a rate of 136,000 + 38,000 per
minute at 160 krpm vs. 41,000 + 11,000 per minute at 140 krpm (p <
0.0001). Aggregates rmunted ranged from 20 to 300 #m in diameter. All of
thesamplesfmmthe X30krpmgroupvs. onlyoneof theaampleefrom the 140
krpm group demonstrated aggregates larger than 100 ~m. The clotting tima
was less than 8 hours in samples exposed to 180 krpm and greater tha,24
hours in samples treated at 140 krpm. Cone/usion:This study demonafrates
that platelet activation and subsequent platalet aggravation occurs during
rotational ablation and Is highly dependent on rotational speed. A dacreaae
in platform speed of 40 krpm will significantly reduce the quantify and size of
platelet aggregates formed. This may have important clinical implications in
the application of this device.
